Lidogab Gel is a topical pharmaceutical formulation containing Gabapentin 6% w/w and Lidocaine 5% w/w, designed for the management of neuropathic pain and localized peripheral nerve pain. Gabapentin, an anticonvulsant agent, modulates calcium channels to inhibit excitatory neurotransmitter release, thereby reducing neuronal hyperexcitability associated with neuropathic conditions. Lidocaine, a local anesthetic, stabilizes neuronal membranes by blocking sodium channels, providing rapid analgesic and numbing effects at the site of application. The combination of these active ingredients in Lidogab Gel offers a dual mechanism of action, delivering both immediate and sustained pain relief. This topical gel is intended for external use only and should be applied to intact skin over the affected area, avoiding mucous membranes and open wounds. Lidogab Gel is particularly beneficial for patients experiencing postherpetic neuralgia, diabetic neuropathy, or other localized neuropathic pain syndromes where systemic therapy may be contraindicated or poorly tolerated. It is recommended to use the gel as directed by a healthcare professional, typically applied two to three times daily. Adverse effects are generally minimal but may include local skin irritation or hypersensitivity reactions. Lidogab Gel provides an effective, targeted approach to neuropathic pain management with a favorable safety profile.